Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Phase I Study

By Derks Michael   Anzures-Cabrera Judith   Turnbull Lynn   Phelan Mary  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 325-335

Adis International

Access to resources Recommend Favorite

Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer's Disease: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

By Aronson Stephen  

Drugs & Aging, Vol. 26, Iss. 3, 2009-01 ,pp. : 231-239

Adis International

Access to resources Recommend Favorite

Once-Daily Trospium Chloride 60 mg Extended Release in Subjects with Overactive Bladder Syndrome Who Use Multiple Concomitant Medications: Post hoc Analysis of Pooled Data from Two Randomized, Placebo-Controlled Trials

By Sand Peter K.  

Drugs & Aging, Vol. 28, Iss. 2, 2011-02 ,pp. : 151-160

Adis International

Access to resources Recommend Favorite

Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study

By Abler Birgit   Erk Susanne   Walter Henrik  

Psychopharmacology, Vol. 191, Iss. 3, 2007-04 ,pp. : 823-833

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Prulifloxacin on Cardiac Repolarization in Healthy Subjects: A Randomized, Crossover, Double-Blind versus Placebo, Moxifloxacin-Controlled Study

By >   >   Dionisio Paolo  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 5-14

Adis International

Access to resources Recommend Favorite